CHINA MESALAZINE MARKET ANALYSIS

China Mesalazine Market, by Route of Administration (Oral and Rectal), by Application (Ulcerative Colitis, Crohn's Disease, and Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI5371
Pages :102
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

China Mesalazine Market - Key Players

Major players operating in China mesalazine market include Zhejiang Hengkang Pharmaceutical Co. Ltd., Jiangsu Jubang Pharmaceutical Co., Ltd., ALP Pharm Beijing Co., Ltd., Shanghai Pharmaceuticals Holding Co Ltd., Heilongjiang Tianhong Pharmaceutical Co., Ltd., AbbVie Inc., F. Hoffmann-La Roche AG, Takeda Pharmaceuticals Company Limited, GSK Plc., Tillotts Pharma AG, Novartis AG, Salix Pharmaceuticals, FERRING B.V., Viatris Inc., and Dr. Falk Pharma GmbH.